Martingale Asset Management »

Iovance Biotherapeutics shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $87k 11k 8.13

More positions owned by Martingale Asset Management

Microsoft Corporation (MSFT)
Broadcom (AVGO)
Alphabet Inc Class A cs (GOOGL)
Apple (AAPL)
Johnson & Johnson (JNJ)
UnitedHealth (UNH)
Berkshire Hathaway (BRK.B)
Merck & Co (MRK)
Costco Wholesale Corporation (COST)
Procter & Gamble Company (PG)
Visa (V)
Adobe Systems Incorporated (ADBE)
Eli Lilly & Co. (LLY)
Cisco Systems (CSCO)
Intuit (INTU)

View all positions for Martingale Asset Management

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Susquehanna International
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics